August 11 2020

REBOXETINE

List of brands containing reboxetine   

This page contains list of brands of authorized pharmaceutical specialties of the active ingredient reboxetine in the countries listed below:

Australia] [ Brazil] [ Canada] [ France] [ Germany] [ India] [ Italy] [ Japan] [ Mexico] [ Pakistan] [ Puerto Rico] [ Spain] [ Turkey] [ United Kingdom] [ U.S.A]

Given the nature of the pharmaceutical market, some specialties may be unavailable, have been removed from the pharmaceutical market or have changed its name. So that, in no case can take decisions based on the information contained on the page. MEDIZZINE is not responsible for any damage arising from the information provided, which may be incomplete or outdated.

Indications and usage     

Reboxetine belongs to the group of medicines known as antidepressants. Reboxetine is indicated for the treatment of depression and maintaining the improvement achieved in patients who initially responded to treatment.

Medizzine recommends consulting your doctor if you are unsure (or you do not know) why you have been given reboxetine.

Other ingredients of available commercial presentations:

Each tablet contains 5.224 mg reboxetine methanesulfonate equivalent to 4 mg reboxetine. The other ingredients are microcrystalline cellulose, dibasic dihydrate calcium phosphate, crospovidone, hydrated colloidal silica and magnesium stearate.

Warning:

The composition of the various presentations may vary from one country to another. We recommend you consult the information provided by your local supplier.

Before taking reboxetine     

Do not use reboxetine

If you are allergic (hypersensitive) to reboxetine or any of the other ingredients of the medicinal product prescribed to you. If you think may be allergic, ask your doctor.

Allergy symptoms may include:

- Asthma attacks with shortness of breath, audible wheezing or rapid breathing.
- More or less sudden swelling of the face, lips, tongue or elsewhere in the body. It is especially critical if it affects the vocal cords.
- Hives, itching, rash
- Anaphylactic shock (loss of consciousness, paleness, sweating, etc.).

Nor you should take this medicine:

If you are pregnant or think you may be pregnant.
If you are breastfeeding.

Take special care with reboxetine

- If you have or have had seizures (eg, epilepsy), as it can trigger an attack.
- If you have prostate hypertrophy (enlarged prostate) or difficulty passing urine because it can worsen your situation.
- If you have glaucoma (high pressure in the eye), as it may worsen.
- If you have a tendency to hypotension (low blood pressure) or are being treated with drugs to lower blood pressure, as it could be reduced further.
- If you have a heart disease (for example, if you have recently suffered a heart attack), because it can raise your heart rate.
- If you have liver or kidney problems.
- If you are being treated with other medicines to treat depression such as monoamine oxidase inhibitors (MAOIs) or lithium,
- If you have thoughts of suicide or you are thinking about hurting yourself.

Thoughts of suicide and worsening of your depression or anxiety disorder:

If you are depressed and/or have an anxiety disorder, you can sometimes have thoughts of harming or killing yourself. These thoughts can increase at the beginning of treatment with antidepressants since all these medicines take a time to cause its effects, normally about two weeks, but sometimes longer.

It is more likely this happens you:

- If you have previously had thoughts of suicide or harming.
- If you are a young adult. Information available from clinical trials shows that there is an increased risk of suicidal behavior in adults aged less than 25 years with psychiatric conditions who were being treated with antidepressants.

If you have thoughts of harming or killing yourself at any time, contact your doctor or go to a hospital immediately.

It may be helpful to tell a relative or close friend that you are depressed or have an anxiety disorder, and ask them to read the leaflet accompanying the package. You might ask them to tell you if they think your depression or anxiety is getting worse, or if they are worried about changes in your behavior.

If you have any questions about this, check with your doctor before taking reboxetine.

If you suffer any of the conditions described above, contact your doctor before taking this medicine

If in doubt, consult your doctor.

Taking other medicines

Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including herbal products or drugs obtained without a prescription.

The effect of reboxetine treatment may vary if is used along with other medicines.

It is important that your doctor knows if you are being treated with any of the following medications, as may be necessary to modify the dose you should receive:

- Drugs that lower blood pressure (antihypertensive).
- Other antidepressant medicines, such as tricyclic antidepressants monoamine oxidase inhibitors (MAOIs), selective reuptake inhibitors (SSRIs) lithium or fluvoxamine,
- Some classes of antibiotics such as erythromycin.
- Antifungals (medicines to treat fungal infections), as fluconazole or ketoconazole.
- Heart medicines, such as flecainide
. - Medications called immunosuppressants (which reduce the action of the immune system defending the body against foreign agents), such as cyclosporin.
- Drugs which are known as ergot derivatives, used for the treatment of a migraine and Parkinson's disease or to prevent or treat bleeding caused as a result of an abortion or childbirth.

Special physiological situations

Pregnancy and lactation

always consult your doctor or pharmacist before taking any medicine during pregnancy or lactation.

Tell your doctor if you are pregnant or are planning to become pregnant, and if you are breastfeeding. Reboxetine is contraindicated in pregnancy and lactation.

Use in children or adolescents under 18 years

Reboxetine should not normally be used in the treatment of children and adolescents under 18 years. At the same time, you should be aware that there is an increased risk of adverse effects such as suicide attempts, suicidal thoughts and hostility (predominantly aggression, oppositional behavior and anger reaction) in patients under age 18 when they take this class of drugs. Despite this, your doctor may prescribe reboxetine to patients under age 18 if he decides that this drug is the most convenient for the patient.

If the doctor has prescribed reboxetine to a patient under 18 and you want to discuss this, please ask your doctor.

You should inform your doctor if any of the symptoms listed above develop or worsen when patients under 18 years are taking reboxetine. At the same time, the long-term effects with regard to safety, growth, maturation and cognitive and behavioral development of reboxetine in this age group have not yet been demonstrated.

Driving and using machines

Caution is advised when driving or operating machines. Do not drive or operate any tools or machines, while you are taking reboxetine, until you know how it affects your abilities, avoiding these activities which may endanger to you or other.

How to use reboxetine     

Follow carefully instructions of use of reboxetine provided from your doctor. Consult your doctor or pharmacist when in doubt. Follow the instructions of the physician in preference to those given in this website, which may be different. Ask your doctor to explain any aspect that you do not understand, contained in the instruction leaflet that comes with the medicine.

Your doctor will tell you the proper dose and duration of treatment with reboxetine. Do not stop treatment earlier.

The recommended dose is as follows:

Adults:

The usual dose is 8 mg per day (one 4 mg tablet twice a day, orally administered)

Your doctor may increase this dose up to 10 mg a day if he considers that the response to treatment is insufficient. The maximum daily dose should not exceed 12 mg daily.

Children:

Reboxetine is not recommended for children.

Elderly:

Reboxetine is not recommended for elderly patients.

Patients with renal or hepatic impairment:

If you have kidney or liver failure, your doctor may need to adjust the reboxetine dose that you should take. The starting dose is 4 mg per day (half a tablet twice a day). However, your doctor may increase the dose depending on the individual response of each patient.

The reboxetine tablets are to be swallowed whole with a glass of water. Do not chew the tablets.

Remember to take this medicine every day. To make it easier to remember, take the medicine at the same time every day.

As with other drugs, reboxetine does not improve your symptoms immediately. You start to feel better after a few weeks elapsed. Treatment may last several months. It is important that you continue to take your tablets, even though you are feeling better until your doctor tells you to stop treatment. If you stop treatment too soon, your symptoms may reoccur

Do not change your dose or stop treatment without consulting your doctor.

If you think the effect of the medicine is too strong or too weak, consult your doctor.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

While you take reboxetine     

If you become pregnant , consult your doctor immediately.

If a doctor prescribes another medicine, tell you are taking reboxetine.

Check with your doctor regularly developments of disorder that motivates the use of reboxetine. Maybe there is some reason that prevented you properly receive the indicated doses and induce your doctor to erroneous conclusions about treatment.

Do not restart treatment with reboxetine at your own risk without first talking to your doctor, nor encourage its use by another person, even if have the same symptoms you have. Nor is it advisable to interrupt or reduce the dose without considering the opinion of your doctor.

If you feel unwell during treatment with reboxetine, immediately consult your doctor.

If you take more than you should:

You should never take more tablets than recommended by your doctor. If you have taken more tablets than you should, contact your doctor or go to the nearest hospital immediately.

If you forget to take reboxetine:

If you miss a reboxetine dose, do not take a double dose to make up for a forgotten dose. Wait until be the time for the next dose; treatment should continue with the administration of the next dose as usual.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

Side Effects of reboxetine     

Like all medicines, reboxetine can cause side effects although not everybody gets them.

The frequency of side effects is classified into:

Very common: affect 1 out of 1-10 patients
Common: affect 1 out of 10-100 patients
Uncommon: affect 1 out of 100-1.000 patients
Rare: affect 1 out of 1.000-10.000 patients
Very Rare: affect less than 1 in 10,000 patients
Incidence not known: Can not be established the true incidence from the available data

When administered reboxetine, most of the side effects that occur are minor and disappear during the first weeks of treatment.

Very common side effects

- Difficulty sleeping (insomnia),
- Dry mouth, constipation
- Sweating

Common side effects

- Vertigo, headache.
- Increased heart rate (tachycardia), palpitations, vasodilation, postural hypotension (dizziness when changing position suddenly)
- Inability to focus vision and blurred vision
- Lack or loss of appetite, nausea
- Difficulty passing urine, sensation of incomplete emptying of the bladder, urinary tract infection
- Difficulty experiencing or maintaining an erection (erectile dysfunction), pain in the testicles, pain during ejaculation or delayed ejaculation.
- Chills

In addition, adverse effects are reported such as anxiety, irritability, aggressive behavior, hallucinations, cold extremities, nausea, vomiting, abnormal tingling, numbness or burning sensation (paresthesia), arterial hypertension and skin lesions or allergic irritation.

This list does not include all adverse reactions associated with the use of reboxetine, both well established as those that are under consideration or confirmation. In case you feel unwell, should immediately consult with the doctor who prescribed this medicine.

If you notice any side effects not listed in this website or in the leaflet accompanying the package, ask your doctor or pharmacist.

If any of the side effects gets serious, tell your doctor or pharmacist.

List of brands containing reboxetine     

This page contains list of brands of authorized pharmaceutical specialties of the active principle reboxetine in the countries listed below:

Australia] [ Brazil] [ Canada] [ France] [ Germany] [ India] [ Italy] [ Japan] [ Mexico] [ Pakistan] [ Puerto Rico] [ Spain] [ Turkey] [ United Kingdom] [ U.S.A]

Given the nature of the pharmaceutical market, some specialties may be unavailable, have been removed from the pharmaceutical market or have changed its name. So that, in no case can take decisions based on the information contained on the page. MEDIZZINE is not responsible for any damage arising from the information provided, which may be incomplete or outdated.

Warning:

With exceptions expressly indicated, these lists do not include active principle associations with other drugs or clinical use containers.

Australia:     

EDRONAX 4 mg, 60 tablets

Brazil:     

PROLIFT 4 mg, 20 tablets

Canada:     

N/A

France:     

N/A

Germany:     

EDRONAX 4 mg, tablets
SOLVEX 4 mg, tablets

India:     

NAREBOX 2 mg, tablets
NAREBOX 4 mg, tablets
REBOOT 2 mg, tablets
REBOOT 4 mg, tablets
REBOTIN 2 mg, tablets
REBOTIN 4 mg, tablets
REBOXXIN 2 mg, tablets
REBOXXIN 4 mg, tablets

Italy:     

DAVEDAX 4 mg, 20 & 60 tablets
EDRONAX 4 mg, 20 & 60 tablets

Japan:     

N/A

Mexico:     

EDRONAX 4 mg, 30 & 60 tablets

Pakistan:     

N/A

Spain:     

IRENOR 4 mg, 20 & 60 tablets
NOREBOX 4 mg, 20 & 60 tablets

Turkey:     

EDRONAX 4 mg, 60 tablets

United Kingdom:     

EDRONAX 4 mg, 60 tablets

U.S.A. and Puerto Rico:     

N/A

Page updated: December 18, 2009.